Genmab A/S logo

Genmab A/S

GMAB | NASDAQ
Chart Builder DCF Calculator
$34.69
-$0.05 (-0.14%)
At close: Sep 21, 2026, 4:00 PM ET
$34.53
-$0.16 (-0.46%)
Pre-market: Sep 22, 2026, 6:51 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Revenue
3.72B 21.53B 16.47B 14.51B 8.42B 10.11B
Cost of Revenue
309.24M 985M 226M n/a n/a n/a
Gross Profit
3.41B 20.54B 16.25B 14.51B 8.42B 10.11B
Operating Income
1.25B 6.7B 5.32B 6.27B 2.95B 6.31B
Interest Income
138.11M 995M 939M 324M 197M 184M
Pretax Income
1.2B 9.16B 5.64B 6.95B 3.92B 5.9B
Net Income
963.76M 7.84B 4.35B 5.45B 2.96B 4.76B
Selling & General & Admin
602.47M 3.79B 3.3B 2.68B 1.28B 661M
Research & Development
1.56B 9.75B 7.63B 5.56B 4.18B 3.14B
Other Expenses
n/a 300M n/a n/a n/a n/a
Operating Expenses
2.16B 13.84B 10.93B 8.24B 5.46B 3.8B
Interest Expense
61.05M 120M 27M 21M 13M 10M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.47B 14.82B 11.15B 8.24B 5.46B 3.8B
Income Tax Expense
241.19M 1.32B 1.29B 1.49B 961M 1.15B
Shares Outstanding (Basic)
621.51M 646.34M 659.19M 653.87M 653.96M 651.79M
Shares Outstanding (Diluted)
626.92M 646.33M 659.15M 660.1M 660.46M 658.86M
EPS (Basic)
1.55 12.14 6.60 8.34 4.52 7.30
EPS (Diluted)
1.54 12.14 6.60 8.26 4.48 7.22
EBITDA
1.34B 9.7B 5.95B 7.35B 4.18B 6.16B
EBIT
1.27B 9.28B 5.71B 6.97B 3.93B 5.91B
Depreciation & Amortization
71.06M 413M 240M 362M 250M 246M

© 2026 bestshares.com. All rights reserved.